Cytochrome P450 and Other Drug-Metabolizing Enzymes As Therapeutic Targets
Drug Metabolism and Disposition · 2023-08 · 51 (8) · 936-949
DOI: 10.1124/dmd.122.001011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Metabolism and Disposition, 2023-08. Verfasst von Robert S Foti. Beteiligte Einrichtung: ADME & Discovery Toxicology, Merck & Co., Inc., Boston, Massachusetts robert.foti@merck.com. Hauptthemen laut MEDLINE: Cytochrome P-450 Enzyme System, Signal Transduction. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 253 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- ADME & Discovery Toxicology, Merck & Co., Inc., Boston, Massachusetts robert.foti@merck.com.
Zitieren
APA
Foti, R. S. (2023). Cytochrome P450 and Other Drug-Metabolizing Enzymes As Therapeutic Targets. Drug Metabolism and Disposition, 51(8), 936-949. https://doi.org/10.1124/dmd.122.001011
Vancouver
Foti RS. Cytochrome P450 and Other Drug-Metabolizing Enzymes As Therapeutic Targets. Drug Metabolism and Disposition. 2023;51(8):936-949. doi:10.1124/dmd.122.001011
BibTeX
@article{Foti2023,
author = {Foti, Robert S},
title = {Cytochrome P450 and Other Drug-Metabolizing Enzymes As Therapeutic Targets},
journal = {Drug Metabolism and Disposition},
year = {2023},
volume = {51},
number = {8},
pages = {936--949},
doi = {10.1124/dmd.122.001011}
}
EUVIMED